Get started
Author

Jamyia Clark

Observed name: J. Clark
ORCID: 0000-0001-9475-4273
Observed ORCID: 0000-0001-9475-4273
OpenAlex ID: A5029008108
Treatment patterns and outcomes among mantle cell lymphoma patients treated with ibrutinib in the United States: a retrospective electronic medical record database and chart review study
2020 · Jeff Sharman, Shaum M. Kabadi, et al. · British Journal of Haematology · 25
PDF
Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors
2020 · Eric Nadler, Melissa Pavilack, et al. · Advances in Therapy · 21
Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices
2018 · A. Scott Paulson, Lisa M. Hess, et al. · Gastric Cancer · 17
PDF
Biomarker Testing Rates in Patients with Advanced Non-Small Cell Lung Cancer Treated in the Community
2019 · Eric Nadler, Melissa Pavilack, et al. · Journal of Cancer Therapy · 11
PDF
Real-World Adherence to National Comprehensive Cancer Network (NCCN) Guidelines Regarding the Usage of PET/CT and Reported Deauville Scores in Advanced Stage Classical Hodgkin Lymphoma: A Community Oncology Practice Perspective
2020 · Christopher A. Yasenchak, Jamyia Clark, et al. · Blood · 3
Treatment Patterns and Outcomes of Patients with Relapsed or Refractory Follicular Lymphoma Treated with Idelalisib in a Community Oncology Setting
2019 · David Andorsky, Rebecca J Chan, et al. · Blood · 3
Treatment Patterns and Outcomes of 159 Ibrutinib-Treated MCL Patients in the United States: A Retrospective Electronic Medical Record Database and Chart Review Study
2018 · Jeff Sharman, Shaum Kabadi, et al. · Blood · 3
Nurse Treatment Preferences Survey for Intravenous Rituximab Infusion Versus Subcutaneous Rituximab Injection: A Real-World Study
2019 · Mitul D. Gandhi, Sheila Shapouri, et al. · Blood · 1
Predictive factors associated with ramucirumab monotherapy or combination therapy among patients with gastric/gastroesophageal junction cancer in the community oncology setting
2017 · William Schelman, A. Paulson, et al. · Annals of Oncology · 1
Real-world use of first-line chemotherapy in post-menopausal patients with HR-positive HER2-negative metastatic breast cancer (mBC) in a US community oncology network.
2016 · Debra A. Patt, Xiaolong Jiao, et al. · Journal of Clinical Oncology · 1
A Real-World Assessment of Hepatic Dysfunction Among Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Receiving First-Line (1L) Tyrosine Kinase Inhibitors (TKIs) in the United States
2020 · Kathryn Kolibaba, Jie Zhou, et al. · Blood
P1.16-36 Treatment Patterns Among Patients with EGFRm NSCLC Treated in the US Community Oncology Setting
2019 · E. Nadler, M. Pavilack, et al. · Journal of Thoracic Oncology
PDF
Understanding epidermal growth factor receptor mutation (EGFRm) testing in patients (pts) with non-small cell lung cancer (NSCLC) in a large community oncology network.
2018 · Eric Nadler, Ancilla Fernandes, et al. · Journal of Clinical Oncology
Clinical Profiles, Treatment Characteristics and Outcomes Among Newly Diagnosed Hodgkin Lymphoma Patients Presenting with Unfavorable and Advanced Disease within a US Community Oncology Setting
2017 · Christopher A. Yasenchak, Joseph Feliciano, et al. · Blood
Management of Elderly Patients with Diffuse Large B-Cell Lymphoma in a Network of Community Oncology Practices in the United States
2016 · John M Burke, Jenny L Black-Shinn, et al. · Blood
Works count: 16
Citation count: 86
H-index: 4
I10-index: 4
Year
Topic
Type